| # | Drug | Count |
|---|---|---|
| 0 | ACLIDINIUM BROMIDE | 1 |
| 1 | AMLODIPINE BESYLATE | 1 |
| 2 | ATORVASTATIN CALCIUM | 1 |
| 3 | BEVACIZUMAB | 1 |
| 4 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 |
| 5 | FLUOROURACIL | 1 |
| 6 | FLUOROURACIL CREAM, 0.5% | 1 |
| 7 | FRUQUINTINIB | 1 |
| 8 | ORAL SEMAGLUTIDE | 1 |
| 9 | OSILODROSTAT | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OSILODROSTAT | 1 | 0.0005 |
| 1 | FRUQUINTINIB | 1 | 0.0003 |
| 2 | ACLIDINIUM BROMIDE | 1 | 0.0002 |
| 3 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| 4 | PANITUMUMAB | 1 | 0.0001 |
| 5 | OXALIPLATIN | 1 | 0.0000 |
| 6 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 7 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| 8 | FLUOROURACIL | 1 | 0.0000 |
| 9 | BEVACIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |